← Back to Search

Health Education Campaign for Melanoma

N/A

Recruiting

Led By Sancy A Leachman, MD, PhD

Research Sponsored by OHSU Knight Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at whether a health education campaign can increase early detection of melanoma in Oregon. The campaign may provide information on the early signs of melanoma. Increased education in Oregon may decrease the number of people who die from melanoma.

Who is the study for?

This trial is open to everyone in Oregon, including individuals interested in melanoma awareness, patients with melanoma, skin care professionals, and healthcare providers. The goal is to educate these groups on early signs of melanoma.

What is being tested?

The study tests the effectiveness of a health education campaign aimed at increasing early detection of melanoma through educational materials, media campaigns, and surveys.

What are the potential side effects?

Since this trial involves an educational intervention rather than medication or medical procedures, there are no direct physical side effects associated with participation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Cancer data collection (correlation with demographic and geographic factors)

Cost data

Reach of educational campaign

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Prevention (health educational campaign)Experimental Treatment4 Interventions

MEDIA CAMPAIGN: Participants view digital media strategies. PRIMARY CARE PROVIDERS AND PROFESSIONALS: Primary care providers and professionals who see skin and potential melanomas receive online based curriculum on melanoma. Participants also complete a survey to assess knowledge and confidence before and after receiving the curriculum. MELANOMA COMMUNITY REGISTRY VOLUNTEERS: Melanoma Community Registry volunteers in Oregon receive educational and training materials on melanoma. Participants also complete a survey before and after receiving educational material. HIGH SCHOOL STUDENTS: High school students receive an educational lecture over 1 hour on sun-safety and early detection of melanoma practices. Participants also complete a survey before and after the educational lecture.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Health Education

2014

Completed Phase 3

~4410

Do I qualify?Apply below to find out